immunogenicity

Bharat Biotech Announces Phase 3 Results of COVAXIN

HYDERABAD:Bharat Biotech, a global leader in vaccine innovation, developing vaccines for infectious diseases, today announced the first interim analysis of…

3 years ago

Nod to Serum Institute of India for Phase 2, 3 Human Clinical Trials of Oxford Vaccine Candidate

NEW DELHI: The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for…

4 years ago

Phase II Trial Finds Chinese COVID-19 Vaccine is Safe, Induces Immune Response

BEIJING: A phase II clinical trial of a COVID-19 vaccine candidate, conducted in China, has found that it is safe…

4 years ago

Novavax Begins Clinical Trial of Covid-19 Vaccine in Australia

SYDNEY: US-based biotechnology company Novavax has started enrolling participants in Australia for a clinical trial of its coronavirus vaccine candidate,…

4 years ago

This website uses cookies.